Conditions: Oral Pre-malignant Lesion(s); Intra-epithelial Neoplasias; History of Invasive Oral Cancer
Intervention: Drug: Pembrolizumab
Sponsors: M.D. Anderson Cancer Center; Merck Sharp & Dohme Corp.
Not yet recruiting - verified August 2016
from #ORL via xlomafota13 on Inoreader http://ift.tt/2bXk6cl
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου